These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3054741)

  • 21. The antibacterial activity of ticarcillin/clavulanic acid (BRL28500) against ticarcillin-resistant bacteria.
    Kasai T; Nishino T; Kazuno Y; Tanino T
    J Antibiot (Tokyo); 1986 Oct; 39(10):1450-60. PubMed ID: 3536827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro susceptibilities of Escherichia coli and Klebsiella spp. to ampicillin-sulbactam and amoxicillin-clavulanic acid.
    Kacmaz B; Sultan N
    Jpn J Infect Dis; 2007 Jul; 60(4):227-9. PubMed ID: 17642541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro effect of ceftriaxone on hospital bacteria. Line of regression and critical values].
    Cluzel M; Chanal M; Sirot D; Sirot J; Cluzel R
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):473-6. PubMed ID: 3937122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of mecillinam and amoxicillin/clavulanic acid against strains of Escherichia coli producing TEM-1, Oxa-1 and chromosomal beta-lactamases.
    Marre R; Schulz E
    Arzneimittelforschung; 1988 Jul; 38(7):863-5. PubMed ID: 3061383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Profile of antimicrobial resistance of agents causing urinary tract infections in children].
    Ghedira Besbes L; Messaoudi A; Ben Meriem C; Guediche MN
    Tunis Med; 2004 Mar; 82(3):299-305. PubMed ID: 15382465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitivity to augmentin and cephalosporines of some bacterial strains isolated from hospitalized patients.
    Debeleac L; Iancu A; Tudorache D; Iancu G
    Rom J Intern Med; 1995; 33(3-4):227-35. PubMed ID: 8646195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of an amoxicillin-clavulanic acid combination on the aerobic fecal flora in children].
    Borderon JC; Rastegar A; Rolland JC; Laugier J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):569-72. PubMed ID: 3937129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: a phase I, open-label, noncomparative clinical trial in healthy volunteers.
    Ponte C; Gracia M; Giménez MJ; Aguilar L; Maín CM; Carpintero Y; Huelves L; Carcas A; del Prado G; Soriano F
    Clin Ther; 2005 Jul; 27(7):1043-9. PubMed ID: 16154483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity and in vivo evaluation of ticarcillin plus clavulanic acid against aerobic and anaerobic bacteria.
    Bansal MB; Chuah SK; Thadepalli H
    Am J Med; 1985 Nov; 79(5B):33-8. PubMed ID: 4073093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The activity of ticarcillin in combination with clavulanic acid against Bacteroides species: an in-vitro comparison with other antibiotics.
    de Barbeyrac B; Quentin C; Bébéar C
    J Antimicrob Chemother; 1986 May; 17 Suppl C():35-9. PubMed ID: 3636337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proposed interpretive criteria and quality control parameters for testing susceptibility of Neisseria gonorrhoeae to beta-lactam-clavulanate combinations.
    Fuchs PC; Barry AL; Baker CN; Murray PR; Washington JA
    J Clin Microbiol; 1992 Aug; 30(8):2191-4. PubMed ID: 1500533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [False sensitivity of Enterococcus faecium to amoxicillin-clavulanic acid with the MicroScan system].
    Joyanes P; Pascual A; Suárez AI; Martínez-Martínez L
    Enferm Infecc Microbiol Clin; 1995 Feb; 13(2):96-8. PubMed ID: 7711133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ticarcillin/clavulanic acid treatment of gynecological infections.
    Gutschow K; Weissenbacher ER; Wachter I; Schneider A; Adam D; Götz A
    Acta Eur Fertil; 1987; 18(2):123-4. PubMed ID: 3630573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro demonstration of a true post-beta-lactamases inhibitor effect (PLIE) of clavulanic acid on Klebsiella pneumoniae and Haemophilus influenzae].
    Murbach V; Dhoyen N; Linger L; Monteil H; Jehl F
    Pathol Biol (Paris); 1999 May; 47(5):462-8. PubMed ID: 10418019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P; Metan G; Hasçelik G; Akova M
    Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combined antibacterial activity of clavulanic acid with amoxicillin and ampicillin against Gram-negative strains].
    Mascellino MT; Prignano G; Lorenzi A; Iegri F; Martorano E; Catania S; Ginanni Corradini S
    Boll Ist Sieroter Milan; 1984; 63(5):447-52. PubMed ID: 6335660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacodynamic basis for the use of amoxicillin-clavulanic acid in respiratory infections due to Streptococcus pneumoniae: In vitro studies in an experimental model].
    Gómez-Lus ML; García Y; Valero E; Amores R; Fuentes F
    Rev Esp Quimioter; 2000 Sep; 13(3):306-13. PubMed ID: 11086282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urine bactericidal activity against resistant Escherichia coli in an in vitro pharmacodynamic model simulating urine concentrations obtained after 2000/125 mg sustained-release co-amoxiclav and 400 mg norfloxacin administration.
    Alou L; Aguilar L; Sevillano D; Giménez MJ; Cafini F; Valero E; Relaño MT; Prieto J
    J Antimicrob Chemother; 2006 Apr; 57(4):714-9. PubMed ID: 16492718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential effects of amoxycillin/clavulanic acid and ticarcillin/clavulanic acid on human granulocyte activity: a comparative study.
    Cuffini AM; Tullio V; Paizis G; Carlone NA
    J Antimicrob Chemother; 1996 Dec; 38(6):1013-22. PubMed ID: 9023648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral antibiotics for infections due to multidrug-resistant Gram-negative organisms.
    Glasser JS; Markelz AE; Zera WC; Beckius ML; Mende K; Murray CK
    Scand J Infect Dis; 2011 Aug; 43(8):649-51. PubMed ID: 21466257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.